Skip to content

A clinical trial to study the effects of two drugs,vati of rasanjan,laksha and aja ksheera and tablet progesterone in patients with heavy menstrual bleeding

A randomised controlled clinical study to compare efficacy of vati of rasanjan,laksha and aja ksheera in comparison with tablet progesterone in the management of asrugdar(menorrhagia)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051900
Enrollment
56
Registered
2023-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

None listed

Sponsors

Tilak Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 age group- 25-50 years 2 Increased number of bleeding days i.e more than 7days 3 Quantitave increase in menstrual blood i.e more than 80ml or more than 3 pads per day 4 Decreased intermenstrual period i.e lessthan 21 days 5 Fibroid uterus

Exclusion criteria

Exclusion criteria: 1 Traumatic bleeding 2 Post-menopausal bleeding 3 Cervical, uterine, ovarianneoplasm 4 Coagulopathy 5 Endometriosis 6 Bleeding through gravid uterus 7 Cervical polyp 8 Cervical erosion 9 Hyertensive Disorders, DM, Bleeding disorders, Cardiac diseases 10 Severe anemia( Hb 11 HIV,HbsAg,VDRL,HPV positive 12 Congenital anomalies of genital tract 13 Patient requiring emergency management

Design outcomes

Primary

MeasureTime frame
1 To assess decrease in number of menstrual bleeding days 2 To assess quantitave decrease in menstrual bleeding 3 To assess relief in Katishool(lower abdominal pain) 4 Artavgrahitatwa(consistency presence of clots in menstrual blood)Timepoint: 3 months

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Rahul J Garudkar

Tilak Ayurved Mahavidyalaya

drrahulgarudkar@yahoo.com9822777367

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026